Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients
November 11, 2021 17:52 ET
|
Adaptive Biotechnologies
Local coverage determination (LCD) confirms access to the only FDA-cleared in vitro diagnostic to detect and monitor minimal residual disease (MRD) from bone marrow and blood sample types in certain...
Aptose Clinical Data to be Presented at the 2021 ASH Annual Meeting
November 04, 2021 09:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
Plasma Fractionation Market Size ($40,731.98Mn by 2028) Lead by Immunoglobulin (6.3% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
November 02, 2021 14:43 ET
|
The Insight Partners
New York, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Plasma Fractionation Market: Key InsightsAccording to our latest study on Plasma Fractionation Market Size, Share, Revenue, Forecast to 2028 - COVID-19...
Point-of-Care Molecular Diagnostics Market Size ($5,381.18Mn by 2028) Lead by Assays and Kits (13.4% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 13:28 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Point-of-Care Molecular Diagnostics Market: Key InsightsAccording to our new research study on Point-of-Care Molecular Diagnostics Market Size and...
Plasma Fractionation Market Worth $41.4 Billion by 2027 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
October 21, 2021 12:30 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Oct. 21, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous),...
Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunotherapy for Treatments of Hematology, Oncology, and Virology
October 04, 2021 09:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s research into the systemic administration of Provectus’ investigational...
Starton Therapeutics Announces Successful Results in STAR-LLD Toxicology Study: No Myelosuppression and Excellent Tolerability
September 30, 2021 07:10 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary dermal technologies,...
American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute
September 22, 2021 08:00 ET
|
American Oncology Network
Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner...
Genesis Cancer Center Announces Rebranding, Changes Name to Genesis Cancer and Blood Institute
September 16, 2021 07:48 ET
|
American Oncology Network
Fort Myers, Fla. & Hot Springs, Ark., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Genesis Cancer Center (Genesis), serving Hot Springs and surrounding communities in oncology/hematology, recently...
The Quality Cancer Care Alliance Adds Cancer Center of Middle Georgia (CCMG) to Its National Network
September 07, 2021 09:00 ET
|
Quality Cancer Care Alliance Network
PUYALLUP, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Continuing its expansion across the country, Quality Cancer Care Alliance Network (QCCAN) is delighted to announce the addition of the Cancer...